Major Research Areas

Publications

Hans-Guido Wendel, Abba Malina, Zhen Zhao, Lars Zender, Scott C. Kogan, Carlos Cordon-Cardo, Jerry Pelletier, and Scott W. Lowe. Sensitivity and resistance to rapamycin-based combination therapy in vivo. Cancer Res. 2006 Aug 1;66(15):7639-46.

Hans-Guido Wendel, Elisa de Stanchina, Enrique Cepero, Sagarika Ray, Jordan S. Friedman, Michael Emig, Darren R. Veach, William G. Bornmann, Bayard Clarkson, W. Richard Mc Combie, Andreas Hochhaus, Scott C. Kogan, and Scott W. Lowe. p53 and targeted cancer therapy. Proc Natl Acad Sci U S A 2006;103:7444-9.

Hans-Guido Wendel, Scott W. Lowe. Reversing drug resistance in vivo. Cell Cycle. 2004 Jul; 3(7): 847-9.

Hans-Guido Wendel, Elisa de Stanchina, Jordan S. Fridman, Abba Malina, Scott C. Kogan, Carlos Cordon-Cardo, Jerry Pelletier, and Scott W. Lowe. Survival signaling by Akt and eIF4E in oncogenesis and cancer therapy. Nature. 2004 Mar 18; 428(6980):332-7.

Hans-Guido Wendel,Ricardo L.A. Silva,Abba Malina, John R. Mills, Hong Zhu, Takeshi Ueda,Rie Watanabe-Fukunaga, Rikiro Fukunaga, Julie Teruya-Feldstein, Jerry Pelletier,and Scott. W. Lowe.Dissecting eIF4E action in tumorigenesis. Genes & Dev. 2007 Dec 15;21(24):3232-7.

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2008 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org